Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
Patients with asthma and T2 diabetes using SGLT2 inhibitors have a significantly decreased mortality risk within 30 days of an asthma exacerbation.
SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases.
Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...
Q: I’m slated to retire next year, and it scares me to death — well, I hope not death, exactly, but I’m not sure what to do ...
I am a 68-year-old woman who is in relatively good health. My primary exercise is walking my dogs anywhere from 2-5 miles per day. I have two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback